NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.49 +0.09 (+3.75%)
At close: Oct 23, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Convertible Debt (2024)

Updated

NRX Pharmaceuticals (NRXP) posted Convertible Debt of $5.01 million for Q4 2024, up 67.9% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Convertible Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 NRX Pharmaceuticals 93.37 Mn 44.96 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.01 Mn
Sep 30, 2024 2.99 Mn
Jun 30, 2024 7.65 Mn
API Access

NRX Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NRXP&period=max&api_key=YOUR_API_KEY